Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures
Open Access
- 20 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 97 (12), 1784-1789
- https://doi.org/10.1002/bjs.7235
Abstract
This study evaluated the safety and haemostatic effectiveness of a fibrin sealant (EVICEL™ Fibrin Sealant (Human)) during vascular surgery. This prospective randomized controlled trial compared the haemostatic effectiveness of fibrin sealant (75 patients) or manual compression (72) in polytetrafluoroethylene (PTFE) arterial anastomoses. The primary endpoint was the absence of bleeding at the anastomosis at 4 min after randomization. Secondary endpoints included haemostasis at 7 and 10 min, treatment failures and the incidence of complications potentially related to bleeding. Adverse events were recorded. A higher percentage of patients who received fibrin sealant versus manual compression achieved haemostasis at 4 min (85 versus 39 per cent respectively; odds ratio 11·34, 95 per cent confidence interval 4·67 to 27·52; P < 0·001). Similarly, a higher percentage of patients who received fibrin sealant achieved haemostasis at 7 and 10 min (both P < 0·001). The incidence of treatment failure was lower in the fibrin sealant group (P < 0·001). The rate of complications potentially related to bleeding was similar (P = 0·426). Some 64 per cent of patients who received fibrin sealant experienced at least one adverse event, compared with 71 per cent who received manual compression. This fibrin sealant was safe, and significantly shortened the time to haemostasis in vascular procedures using PTFE. Registration number: NCT00154141 (http://www.clinicaltrials.gov).Keywords
Funding Information
- Johnson & Johnson Wound Management
This publication has 14 references indexed in Scilit:
- High-Dose Tranexamic Acid Is Associated with Nonischemic Clinical Seizures in Cardiac Surgical PatientsAnesthesia & Analgesia, 2010
- Declaration of Helsinki. Ethical Principles for Medical Research Involving Human SubjectsJahrbuch für Wissenschaft und Ethik, 2009
- The Risks of Aprotinin and Tranexamic Acid in Cardiac Surgery: A One-Year Follow-Up of 1188 Consecutive PatientsAnesthesia & Analgesia, 2008
- Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trialLangenbecks Archives Of Surgery, 2005
- Comparison of a New Fibrin Sealant With Standard Topical Hemostatic AgentsArchives of Surgery, 2004
- Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery graftsJournal of Vascular Surgery, 2003
- Fibrin Sealant Improves Hemostasis in Peripheral Vascular Surgery: A Randomized Prospective TrialAnnals of Surgery, 2003
- Use of Fibrin Sealant to Reduce Bloody Drainage and Hemoglobin Loss After Total Knee ArthroplastyThe Journal of Bone and Joint Surgery-American Volume, 2001
- Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Prospective, randomized evaluation of the efficacy of fibrin sealant as a topical hemostatic agent at the cannulation site in neonates undergoing extracorporeal membrane oxygenationThe American Journal of Surgery, 1997